Cary Street Partners Investment Advisory’s Nuveen Short-Term REIT ETF NURE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-3,600
Closed -$109K 1711
2022
Q4
$102K Buy
+3,600
New +$106K 0.01% 579
2022
Q2
Sell
-6,100
Closed -$239K 558
2022
Q1
$239K Sell
6,100
-150
-2% -$5.72K 0.07% 241
2021
Q4
$255K Buy
+6,250
New +$238K 0.07% 228

Other funds holding NURE

Cary Street Partners Investment Advisory's NURE Position: Q1 2023 in Review

Cary Street Partners Investment Advisory sold out of Nuveen Short-Term REIT ETF (NURE) in Q1 2023, closing a stake of 3,600 shares — an estimated $109K sold.

Cary Street Partners Investment Advisory first reported a position in NURE in Q4 2021 and held it in 3 quarters. The position peaked at $255K in Q4 2021. 33 funds tracked by Wall St. Rank hold NURE as of Q1 2023.

  • Cary Street Partners Investment Advisory reported no remaining Nuveen Short-Term REIT ETF position as of Q1 2023 after selling out during the quarter.
  • Cary Street Partners Investment Advisory sold 3,600 Nuveen Short-Term REIT ETF shares in Q1 2023, an estimated $109K.
  • Cary Street Partners Investment Advisory first reported a position in Nuveen Short-Term REIT ETF in Q4 2021 and held it in 3 quarters.
  • Cary Street Partners Investment Advisory's Nuveen Short-Term REIT ETF position peaked at $255K in Q4 2021.
  • 33 funds tracked by Wall St. Rank held Nuveen Short-Term REIT ETF as of Q1 2023.

Based on Cary Street Partners Investment Advisory's 13F filing for Q1 2023, filed 12 May 2023.